Axactor (ACR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Apr, 2026Executive summary
Q4 saw revenue growth in both NPL and 3PC segments, with NPL gross revenue up 3% year-over-year and 3PC up 16%, supported by strong collection performance at 106% for Q4 and 102% for the year.
Cash EBITDA increased to EUR 54 million from EUR 51 million last year, with margin rising to 64%.
Portfolio sales in Germany and Spain at a premium to book value strengthened the balance sheet and renewed the NPL book.
2025 highlights included 19% organic growth in 3PC, improved collection performance, successful refinancing, and a 30% reduction in IT infrastructure costs.
Annualized return on equity reached 10% for Q4 2025, or 14% excluding non-recurring costs, driven by revenue growth and reduced interest expenses.
Financial highlights
Q4 2025 gross revenue was EUR 99 million, down 39% year-over-year due to portfolio sales, but underlying like-for-like growth was 6%.
NPL segment gross revenue was EUR 80 million, with 3% underlying growth after adjusting for sales.
3PC segment revenue was EUR 19 million, up 16% year-over-year, with double-digit growth in Norway, Spain, and Germany.
Reported EBITDA was EUR 35 million (52% margin); Cash EBITDA was EUR 67 million, down from EUR 130 million last year due to fewer large portfolio sales.
Return on equity for 2025 was 10%, or 12% excluding non-recurring items, aligning with the 2026 target.
Outlook and guidance
NPL investments for 2025 were EUR 59 million, below the EUR 100–200 million target, but expected to increase as refinancing is complete.
Targeting minimum 12% ROE and maximum leverage ratio of 3.5x by end of 2026.
No dividend will be paid for 2025 to prioritize deleveraging and improve funding costs.
Strong 3PC growth expected to continue in 2026, supported by new large agreements, especially in Norway.
Operational optimization and IT enhancements are underway to further improve efficiency.
Latest events from Axactor
- EUR 200m placement and co-investment deal to drive growth, boost capacity, and reduce leverage.ACR
Investor update29 Apr 2026 - Cash EBITDA up 3% to EUR 61.1M as cost control offsets 2% revenue decline.ACR
Q2 20241 Feb 2026 - Gross revenue up 2% year-over-year, but net profit and ROE to shareholders fell to 0%.ACR
Q3 202417 Jan 2026 - Q4 revenue surged on a Spanish sale, but negative revaluations led to a net loss; liquidity is strong.ACR
Q4 202423 Dec 2025 - Record 12% ROE, 50% EBITDA margin, and 28% 3PC growth highlight strong Q1 results.ACR
Q1 202525 Nov 2025 - Refinancing, strong collections, and 3PC growth support a positive outlook.ACR
Q2 202523 Nov 2025 - Double-digit growth, 53% EBITDA margin, and strong 3PC/NPL performance drive positive outlook.ACR
Q3 202530 Oct 2025 - Spanish portfolio sales and bond buybacks boost Axactor's financial flexibility.ACR
Investor Presentation6 Jun 2025